Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 Jun 15;138(12):1099–1105.

Transient ischemic attacks and stroke.

T R Mirsen 1, V C Hachinski 1
PMCID: PMC1267938  PMID: 3285985

Abstract

Transient ischemic attacks (TIAs) constitute the most specific and powerful warnings of impending stroke. They are defined as brief, focal neurological events of sudden onset. Their proper recognition and treatment rank second only to the modification of risk factors in importance for stroke prevention. Carotid endarterectomy, although widely used to treat TIAs, remains unproven; randomized clinical trials are attempting to define its role. Anticoagulant therapy appears worth while for suspected cardiac embolism and possibly for disabling TIAs. Acetylsalicylic acid is the only agent that has been found to be effective in controlled trials, but questions persist about its dosage, its efficacy in women and its use after stroke. Another platelet inhibitor, ticlopidine hydrochloride, is being investigated and may prove to be an effective alternative.

Full text

PDF
1099

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott R. D., Yin Y., Reed D. M., Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986 Sep 18;315(12):717–720. doi: 10.1056/NEJM198609183151201. [DOI] [PubMed] [Google Scholar]
  2. Acheson J., Danta G., Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J. 1969 Mar 8;1(5644):614–615. doi: 10.1136/bmj.1.5644.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAKER R. N. Anticoagulant therapy in cerebral infarction. Report on cooperative study. Neurology. 1962 Dec;12:823–835. doi: 10.1212/wnl.12.12.823. [DOI] [PubMed] [Google Scholar]
  4. Bousser M. G., Eschwege E., Haguenau M., Lefaucconnier J. M., Thibult N., Touboul D., Touboul P. J. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983 Jan-Feb;14(1):5–14. doi: 10.1161/01.str.14.1.5. [DOI] [PubMed] [Google Scholar]
  5. Brust J. C. Transient ischemic attacks: natural history and anticoagulation. Neurology. 1977 Aug;27(8):701–707. doi: 10.1212/wnl.27.8.701. [DOI] [PubMed] [Google Scholar]
  6. Burén A., Ygge J. Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. Stroke. 1981 Sep-Oct;12(5):578–580. doi: 10.1161/01.str.12.5.578. [DOI] [PubMed] [Google Scholar]
  7. Candelise L., Landi G., Perrone P., Bracchi M., Brambilla G. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke. 1982 Mar-Apr;13(2):175–179. doi: 10.1161/01.str.13.2.175. [DOI] [PubMed] [Google Scholar]
  8. Dyken M. L., Conneally M., Haerer A. F., Gotshall R. A., Calanchini P. R., Poskanzer D. C., Price T. R., Swanson P. D. Cooperative study of hospital frequency and character of transient ischemic attacks. I. Background, organization, and clinical survey. JAMA. 1977 Feb 28;237(9):882–886. [PubMed] [Google Scholar]
  9. Dyken M. L., Pokras R. The performance of endarterectomy for disease of the extracranial arteries of the head. Stroke. 1984 Nov-Dec;15(6):948–950. doi: 10.1161/01.str.15.6.948. [DOI] [PubMed] [Google Scholar]
  10. Dyken M. L. Transient ischemic attacks and aspirin, stroke and death; negative studies and Type II error. Stroke. 1983 Jan-Feb;14(1):2–4. doi: 10.1161/01.str.14.1.2. [DOI] [PubMed] [Google Scholar]
  11. Fields W. S., Maslenikov V., Meyer J. S., Hass W. K., Remington R. D., Macdonald M. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA. 1970 Mar 23;211(12):1993–2003. doi: 10.1001/jama.211.12.1993. [DOI] [PubMed] [Google Scholar]
  12. Ford C. S., Frye J. L., Toole J. F., Lefkowitz D. Asymptomatic carotid bruit and stenosis. A prospective follow-up study. Arch Neurol. 1986 Mar;43(3):219–222. doi: 10.1001/archneur.1986.00520030011004. [DOI] [PubMed] [Google Scholar]
  13. Friedman G. D., Wilson W. S., Mosier J. M., Colandrea M. A., Nichaman M. Z. Transient ischemic attacks in a community. JAMA. 1969 Nov 24;210(8):1428–1434. [PubMed] [Google Scholar]
  14. Futty D. E., Conneally M., Dyken M. L., Price T. R., Haerer A. F., Poskanzer D. C., Swanson P. D., Calanchini P. R., Gotshall R. A. Cooperative study of hospital frequency and character of transient ischemic attacks. V. Symptom analysis. JAMA. 1977 Nov 28;238(22):2386–2390. [PubMed] [Google Scholar]
  15. Gent M., Blakely J. A., Hachinski V., Roberts R. S., Barnett H. J., Bayer N. H., Carruthers S. G., Collins S. M., Gawel M. G., Giroux-Klimek M. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke. 1985 May-Jun;16(3):416–424. doi: 10.1161/01.str.16.3.416. [DOI] [PubMed] [Google Scholar]
  16. Gent M. Single studies and overview analyses: is aspirin of value in cerebral ischemia? Stroke. 1987 May-Jun;18(3):541–544. doi: 10.1161/01.str.18.3.541. [DOI] [PubMed] [Google Scholar]
  17. Genton E., Barnett H. J., Fields W. S., Gent M., Hoak J. C. XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Stroke. 1977 Jan-Feb;8(1):150–175. doi: 10.1161/01.str.8.1.150. [DOI] [PubMed] [Google Scholar]
  18. Gårde A., Samuelsson K., Fahlgren H., Hedberg E., Hjerne L. G., Ostman J. Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke. 1983 Sep-Oct;14(5):677–681. doi: 10.1161/01.str.14.5.677. [DOI] [PubMed] [Google Scholar]
  19. Hachinski V. C., Lassen N. A., Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974 Jul 27;2(7874):207–210. doi: 10.1016/s0140-6736(74)91496-2. [DOI] [PubMed] [Google Scholar]
  20. Harris W. H., Salzman E. W., Athanasoulis C. A., Waltman A. C., DeSanctis R. W. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246–1249. doi: 10.1056/NEJM197712082972302. [DOI] [PubMed] [Google Scholar]
  21. Heyman A., Wilkinson W. E., Hurwitz B. J., Haynes C. S., Utley C. M., Rosati R. A., Burch J. G., Gore T. B. Risk of ischemic heart disease in patients with TIA. Neurology. 1984 May;34(5):626–630. doi: 10.1212/wnl.34.5.626. [DOI] [PubMed] [Google Scholar]
  22. Hirsh J. Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness. Stroke. 1985 Jan-Feb;16(1):1–4. doi: 10.1161/01.str.16.1.1. [DOI] [PubMed] [Google Scholar]
  23. Howard G., Toole J. F., Frye-Pierson J., Hinshelwood L. C. Factors influencing the survival of 451 transient ischemic attack patients. Stroke. 1987 May-Jun;18(3):552–557. doi: 10.1161/01.str.18.3.552. [DOI] [PubMed] [Google Scholar]
  24. Hull R., Hirsh J., Jay R., Carter C., England C., Gent M., Turpie A. G., McLoughlin D., Dodd P., Thomas M. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med. 1982 Dec 30;307(27):1676–1681. doi: 10.1056/NEJM198212303072704. [DOI] [PubMed] [Google Scholar]
  25. Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA. 1970 Oct 12;214(2):301–310. [PubMed] [Google Scholar]
  26. Levine M., Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease. Stroke. 1986 Jan-Feb;17(1):111–116. doi: 10.1161/01.str.17.1.111. [DOI] [PubMed] [Google Scholar]
  27. Muuronen A., Kaste M. Outcome of 314 patients with transient ischemic attacks. Stroke. 1982 Jan-Feb;13(1):24–31. doi: 10.1161/01.str.13.1.24. [DOI] [PubMed] [Google Scholar]
  28. Olsson J. E., Brechter C., Bäcklund H., Krook H., Müller R., Nitelius E., Olsson O., Tornberg A. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke. 1980 Jan-Feb;11(1):4–9. doi: 10.1161/01.str.11.1.4. [DOI] [PubMed] [Google Scholar]
  29. PEARCE J. M., GUBBAY S. S., WALTON J. N. LONG-TERM ANTICOAGULANT THERAPY IN TRANSIENT CEREBRAL ISCHAEMIC ATTACKS. Lancet. 1965 Jan 2;1(7375):6–9. doi: 10.1016/s0140-6736(65)90920-7. [DOI] [PubMed] [Google Scholar]
  30. Pessin M. S., Duncan G. W., Mohr J. P., Poskanzer D. C. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med. 1977 Feb 17;296(7):358–362. doi: 10.1056/NEJM197702172960703. [DOI] [PubMed] [Google Scholar]
  31. Shaw D. A., Venables G. S., Cartlidge N. E., Bates D., Dickinson P. H. Carotid endarterectomy in patients with transient cerebral ischaemia. J Neurol Sci. 1984 Apr;64(1):45–53. doi: 10.1016/0022-510x(84)90054-6. [DOI] [PubMed] [Google Scholar]
  32. Sorensen P. S., Pedersen H., Marquardsen J., Petersson H., Heltberg A., Simonsen N., Munck O., Andersen L. A. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke. 1983 Jan-Feb;14(1):15–22. [PubMed] [Google Scholar]
  33. Toole J. F., Janeway R., Choi K., Cordell R., Davis C., Johnston F., Miller H. S. Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients. Arch Neurol. 1975 Jan;32(1):5–12. doi: 10.1001/archneur.1975.00490430027003. [DOI] [PubMed] [Google Scholar]
  34. Toole J. F., Yuson C. P., Janeway R., Johnston F., Davis C., Cordell A. R., Howard G. Transient ischemic attacks: a prospective study of 225 patients. Neurology. 1978 Aug;28(8):746–753. doi: 10.1212/wnl.28.8.746. [DOI] [PubMed] [Google Scholar]
  35. Warlow C. Carotid endarterectomy: does it work? Stroke. 1984 Nov-Dec;15(6):1068–1076. doi: 10.1161/01.str.15.6.1068. [DOI] [PubMed] [Google Scholar]
  36. Weksler B. B., Lewin M. Anticoagulation in cerebral ischemia. Stroke. 1983 Sep-Oct;14(5):658–663. doi: 10.1161/01.str.14.5.658. [DOI] [PubMed] [Google Scholar]
  37. Whisnant J. P., Matsumoto N., Elveback L. R. The effect of anticoagulant therapy on the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973 Dec;48(12):844–passim. [PubMed] [Google Scholar]
  38. Whisnant J. P., Matsumoto N., Elveback L. R. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973 Mar;48(3):194–198. [PubMed] [Google Scholar]
  39. Whisnant J. P., Sandok B. A., Sundt T. M., Jr Carotid endarterectomy for unilateral carotid system transient cerebral ischemia. Mayo Clin Proc. 1983 Mar;58(3):171–175. [PubMed] [Google Scholar]
  40. Whisnant J. P. The decline of stroke. Stroke. 1984 Jan-Feb;15(1):160–168. doi: 10.1161/01.str.15.1.160. [DOI] [PubMed] [Google Scholar]
  41. Wiebers D. O., Whisnant J. P., O'Fallon W. M. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. Neurology. 1982 May;32(5):459–465. doi: 10.1212/wnl.32.5.459. [DOI] [PubMed] [Google Scholar]
  42. Wolf P. A., Dawber T. R., Thomas H. E., Jr, Kannel W. B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978 Oct;28(10):973–977. doi: 10.1212/wnl.28.10.973. [DOI] [PubMed] [Google Scholar]
  43. Wolf P. A., Kannel W. B., Sorlie P., McNamara P. Asymptomatic carotid bruit and risk of stroke. The Framingham study. JAMA. 1981 Apr 10;245(14):1442–1445. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES